IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $234,189 | -86.8% | 6,623 | -86.0% | 0.00% | -100.0% |
Q2 2022 | $1,776,000 | +633.9% | 47,206 | +615.6% | 0.00% | – |
Q1 2022 | $242,000 | -35.6% | 6,597 | -30.1% | 0.00% | – |
Q2 2021 | $376,000 | -42.0% | 9,435 | -34.5% | 0.00% | -100.0% |
Q1 2021 | $648,000 | -33.6% | 14,415 | -16.8% | 0.00% | 0.0% |
Q4 2020 | $976,000 | -52.7% | 17,334 | -59.9% | 0.00% | -66.7% |
Q3 2020 | $2,064,000 | +181.2% | 43,175 | +247.0% | 0.00% | +200.0% |
Q2 2020 | $734,000 | +36.9% | 12,444 | +10.0% | 0.00% | 0.0% |
Q1 2020 | $536,000 | -82.2% | 11,314 | -77.1% | 0.00% | -80.0% |
Q4 2019 | $3,016,000 | +112.1% | 49,434 | +108.3% | 0.01% | +66.7% |
Q3 2019 | $1,422,000 | +90.9% | 23,727 | +104.9% | 0.00% | +200.0% |
Q2 2019 | $745,000 | +10.4% | 11,580 | +39.3% | 0.00% | 0.0% |
Q1 2019 | $675,000 | +74.4% | 8,311 | -49.9% | 0.00% | 0.0% |
Q2 2016 | $387,000 | -46.5% | 16,599 | -7.0% | 0.00% | -50.0% |
Q1 2016 | $723,000 | -41.4% | 17,846 | -10.4% | 0.00% | -33.3% |
Q4 2015 | $1,234,000 | – | 19,925 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |